Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge
Open Access
- 22 January 2020
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-11
Abstract
Background: Hepatocellular carcinoma (HCC) with hilar bile duct tumor thrombus (HBDTT) often mimic hilar cholangiocarcinoma (hilar CC). The purpose of this study is to analyze the Computed Tomography (CT) characteristics of HCC with HBDTT and to identify imaging features to aid its differentiation from hilar CC on enhanced CT.Methods: We retrospectively identified 58 cases with pathologically proved HCC with HBDTT between 2011 and 2018. Seventy-seven cases of pathologically proven hilar CCs were selected during the same period. The clinical features and CT findings of the two groups were reviewed and compared.Results: HCC with HBDTTs are more commonly found in men (87.9% vs 63.6%,p = 0.001) with lower age of onset (49.84 vs 58.61 years;p < 0.001) in comparison to hilar CCs. Positive correlation were identified between HCC with HBDTTs and chronic HBV infection (72.4% vs 11.7%;p < 0.001), increased serum AFP (67.2% vs 1.3%;p < 0.001), CA19–9 level (58.6% vs 85.7%;p < 0.001) and CEA level (3.4% vs 29.9%;p = 0.001), parenchymal lesion with intraductal lesion (100% vs 18.2%;p < 0.001), washout during the portal venous phase (84.5% vs 6.5%;p < 0.001), thickened bile duct wall (8.6% vs 93.5%;p < 0.001), intrahepatic vascular embolus (44.8% vs 7.8%;p < 0.001), splenomegaly (34.5% vs 2.6%,p < 0.001). A scoring system consisting of the five parameters obtained from characteristics mentioned above was trialed. The sensitivity and specificity for diagnosing HCC with HBDTT were 96.39, 100 and 92.5% respectively when the total score was 2 or more.Conclusions: HCC with HBDTTs are often distinguishable from hilar CCs based on washout during portal venous phase without thickened bile duct wall. HBV infection and serum AFP level facilitate the differentiation.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFC0113402)
- National Natural Science Foundation of China (81771908, 81770645)
- National Natural Science Foundation of China (81571750)
This publication has 47 references indexed in Scilit:
- Radiological diagnosis and staging of hilar cholangiocarcinomaWorld Journal of Gastrointestinal Oncology, 2013
- Hepatocellular Carcinoma With Bile Duct Tumor ThrombusJournal of Computer Assisted Tomography, 2011
- Hepatocellular carcinoma with bile duct tumor thrombi: Correlation of magnetic resonance imaging features to histopathologic manifestationsEuropean Journal of Radiology, 2010
- Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic massWorld Journal of Gastroenterology, 2010
- High lifetime risk of cancer in primary sclerosing cholangitisJournal of Hepatology, 2009
- CholangiocarcinomaHepatology, 2008
- Opisthorchis viverrini: The carcinogenic human liver flukeWorld Journal of Gastroenterology, 2008
- Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan†Hepatology Research, 2007
- Computed Tomography Features of an Intraductal Polypoid MassJournal of Computer Assisted Tomography, 2006
- Three cases of small hepatocellular carcinoma presenting as obstructive jaundiceHPB, 2004